§ 201.6 Drugs; misleading statements.

FederalRegulations

Ask Donna

How this section applies to your facts.

Title 21 CFR: Food and Drugs › Chapter I › Part 201 › Subpart A › § 201.6: § 201.6 Drugs; misleading statements.

This text was captured on Aug 14, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

(a) Among representations in the labeling of a drug which render such drug misbranded is a false or misleading representation with respect to another drug or a device or a food or cosmetic. (b) The labeling of a drug which contains two or more ingredients may be misleading by reason, among other reasons, of the designation of such drug in such labeling by a name which includes or suggests the name of one or more but not all such ingredients, even though the names of all such ingredients are stated elsewhere in the labeling. [41 FR 6908, Feb. 13, 1976]

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

§ 201.6 Drugs; misleading statements. · 21 C.F.R. § 201.6 (2026) | Frix